Karnad A - Search Results

1

The biology and role of CD44 in cancer progression: therapeutic implications.

Chen C, Zhao S, Karnad A, Freeman JW. Chen C, et al. Among authors: karnad a. J Hematol Oncol. 2018 May 10;11(1):64. doi: 10.1186/s13045-018-0605-5. J Hematol Oncol. 2018. PMID: 29747682 Free PMC article. Review.

2

Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets.

Chang K, Karnad A, Zhao S, Freeman JW. Chang K, et al. Among authors: karnad a. Oncotarget. 2015 Feb 28;6(6):3507-18. doi: 10.18632/oncotarget.3420. Oncotarget. 2015. PMID: 25784650 Free PMC article. Review.

3

CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy.

Zhao S, Chen C, Chang K, Karnad A, Jagirdar J, Kumar AP, Freeman JW. Zhao S, et al. Among authors: karnad a. Clin Cancer Res. 2016 Nov 15;22(22):5592-5604. doi: 10.1158/1078-0432.CCR-15-3115. Epub 2016 Jun 7. Clin Cancer Res. 2016. PMID: 27267855 Free PMC article.

4

Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching.

Chen C, Zhao S, Zhao X, Cao L, Karnad A, Kumar AP, Freeman JW. Chen C, et al. Among authors: karnad a. Cell Death Dis. 2022 Aug 5;13(8):682. doi: 10.1038/s41419-022-05103-1. Cell Death Dis. 2022. PMID: 35931675 Free PMC article.

5

Cancer rates, medical comorbidities, and treatment modalities in the oldest patients.

Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE. Zeber JE, et al. Among authors: karnad ab. Crit Rev Oncol Hematol. 2008 Sep;67(3):237-42. doi: 10.1016/j.critrevonc.2008.02.002. Epub 2008 Mar 19. Crit Rev Oncol Hematol. 2008. PMID: 18356072

6

Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials.

Patel SR, Karnad AB, Ketchum NS, Pollock BH, Sarantopoulos J, Weitman S, Mahalingam D. Patel SR, et al. J Gastrointest Oncol. 2014 Apr;5(2):99-103. doi: 10.3978/j.issn.2078-6891.2014.002. J Gastrointest Oncol. 2014. PMID: 24772337 Free PMC article.

7

An evaluation of elderly patients (≥70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011.

Rowe J, Patel S, Mazo-Canola M, Parra A, Goros M, Michalek J, Kelly K, Weitman S, Karnad A. Rowe J, et al. Among authors: karnad a. J Geriatr Oncol. 2014 Jan;5(1):65-70. doi: 10.1016/j.jgo.2013.08.005. Epub 2013 Sep 18. J Geriatr Oncol. 2014. PMID: 24484720 Free PMC article.

8

Hispanic accrual on randomized cancer clinical trials: a call to arms.

Parra A, Karnad AB, Thompson IM. Parra A, et al. Among authors: karnad ab. J Clin Oncol. 2014 Jun 20;32(18):1871-3. doi: 10.1200/JCO.2013.51.7946. Epub 2014 May 19. J Clin Oncol. 2014. PMID: 24841978 Free PMC article. No abstract available.

9

Common toxicities of mammalian target of rapamycin inhibitors.

Soefje SA, Karnad A, Brenner AJ. Soefje SA, et al. Among authors: karnad a. Target Oncol. 2011 Jun;6(2):125-9. doi: 10.1007/s11523-011-0174-9. Epub 2011 Apr 16. Target Oncol. 2011. PMID: 21499766 Review.

10

Breast cancer treatment delays in a majority minority community: is there a difference?

Parsons HM, Lathrop KI, Schmidt S, Mazo-Canola M, Trevino-Jones J, Speck H, Karnad AB. Parsons HM, et al. J Oncol Pract. 2015 Mar;11(2):e144-53. doi: 10.1200/JOP.2014.000141. Epub 2014 Dec 16. J Oncol Pract. 2015. PMID: 25515722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters